Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clomipramine 50mg capsules
0403010F0AAACAC
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | 31,422 |
|
Clomipramine 25mg capsules
0403010F0AAABAB
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | 19,278 |
|
Clomipramine 10mg capsules
0403010F0AAAAAA
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | 11,795 |
|
Clomipramine 50mg/5ml oral suspension
0403010F0AAAQAQ
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | 44 |
|
Clomipramine 75mg modified-release tablets
0403010F0AAARAR
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | 28 |
|
Anafranil SR 75mg tablets
0403010F0BBAFAR
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | 13 |
|
Clomipramine 10mg/5ml oral liquid
0403010F0AAALAL
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | 2 |
|
Anafranil 10mg capsules
0403010F0BBAAAA
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Anafranil 25mg capsules
0403010F0BBABAB
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Anafranil 25mg/2ml solution for injection ampoules
0403010F0BBAEAD
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Anafranil 25mg/5ml syrup
0403010F0BBADAK
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Anafranil 50mg capsules
0403010F0BBACAC
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 250mg/5ml oral suspension
0403010F0AAASAS
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 25mg/2ml solution for injection ampoules
0403010F0AAADAD
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 25mg/5ml oral liquid
0403010F0AAAKAK
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 37.5mg/5ml oral liquid
0403010F0AAAPAP
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 50mg/5ml oral solution
0403010F0AAANAN
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Clomipramine 5mg/5ml oral liquid
0403010F0AAAMAM
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.